Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer
Clinical trial NCT04897009 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04897009
- Sponsor
- Mayo Clinic
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-09
- Primary completion
- 2028-06-08
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.